A randomized, open-label, parallel-group, 6 week treatment, multi-center, phase III study to investigate the efficacy and safety of 100 microg and 200 microg twice daily of budesonide turbuhaler and 50 microg and 100 microg twice daily of fluticasone Diskus in Japanese children with bronchial asthma aged 5-15
Phase of Trial: Phase III
Latest Information Update: 17 Dec 2016
At a glance
- Drugs Budesonide; Fluticasone propionate
- Indications Asthma
- Focus Therapeutic Use
- Sponsors AstraZeneca
- 16 May 2010 Results were presented at the 106th International Conference of the American Thoracic Society.
- 18 Dec 2007 Status change from in progress to completed.
- 10 Aug 2007 New trial record.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History